On the third day of the JPM conference, analysts expressed the opinion that in the stalemate regarding drug prices, the White House and drug manufacturers won [original content]. Sanofi CEO Paul Hudson disagrees[original content]. The pharmaceutical industry has been trying to find a compromise with the White House[original content]. Novo Nordisk focuses on mergers and acquisitions[original content].